| Day 7 (2,657) | Day 14 (n=4,638) | Day 28 (n=4,082) |
---|
 | OR* (95% CI) |
p
| OR*(95% CI) |
p
| OR* (95% CI) |
p
|
---|
Covariates** | Â | Â | Â | Â | Â | Â |
AL | 0.51 (0.28-0.90) |
0.02
| 1.33 (0.95-1.87) |
0.10
| 0.86 (0.54-1.39) |
0.55
|
AS+partners | 0.70 (0.52-0.94) |
0.02
| 0.95 (0.69-1.32) |
0.78
| 0.96 (0.63-1.44) |
0.83
|
AS | 1.36 (0.97-1.92) |
0.08
| 0.99 (0.61-1.59) |
0.96
| 1.07 (0.58-1.96) |
0.83
|
<5 years old | 0.87 (0.68-1.11) |
0.25
| 0.82 (0.65-1.04) |
0.10
| 0.82 (0.60-1.12) |
0.21
|
P.f. day 0 | 1.80 (1.41-2.30 |
<0.001
| 1.68 (1.33-2.12) |
<0.001
| 1.30 (0.96-.75) |
0.09
|
Treat fail | 1.43 (0.88-2.32) |
0.15
| 1.63 (1.13-2.38) |
0.01
| 2.03 (1.44-2.87) |
<0.001
|
- Note: *OR is the odds ratio obtained from generalized linear and latent mixed model with binomial family using site as random effect;
- **Covariates references were: CQ, AQ, SP for day 7 and CQ, AQ, SP and SP-AQ for day 14 and day 28 for treatment, the age ≥ 5 years old for the age group, the 28-day cured parasite outcome after treatment for the treatment failure (Treat fail) outcome, the baseline parasite density was log transformed and treated as continuous variable; AS + partners were: AS-AQ, AS-SP, AS-PYR for day 7, AS-AQ, AS-SP, AS-MEF for day 14 and AS-AQ, AS-SP, AS-PYR, AS-SMP and AS-MEF for day 28.